UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Possibility Of Over 10,000 Fatalities As Venezuela Declares State Of Emergency After Two Large Earthquakes
Oil Prices Dip Again As US-Iran Talks Progress
Keir Starmer Resigns As British Prime Minister
US And Iran Pull Out Of Peace Deal Signing Ceremony
US And Iran Say Deal Reached To End War